Insider buying
~$178K18K sh @ $9.90
Traded Feb 14, 2025 · filed 5 days later
A Mbx Biosciences director paid $178K out of pocket for Mbx Biosciences shares. 2 other people at Mbx Biosciences bought some too, in the same month.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Feb 14, 2025 · Filed Feb 19, 2025
A Mbx Biosciences director paid $291K out of pocket for Mbx Biosciences shares. 2 other people at Mbx Biosciences bought some too, in the same month.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$290,969
Shares × reported transaction price
$100K–$500K
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
3 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
38 days after results of Jan 7, 2025, 31 days before results of Mar 17, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
Insider buying
Traded Feb 14, 2025 · filed 5 days later
A Mbx Biosciences director paid $178K out of pocket for Mbx Biosciences shares. 2 other people at Mbx Biosciences bought some too, in the same month.
Insider buying
Traded Feb 18, 2025 · filed 1 day later
A Mbx Biosciences director paid $532K out of pocket for Mbx Biosciences shares. 2 other people at Mbx Biosciences bought some too, in the same month.
Insider buying
Traded Feb 18, 2025 · filed 1 day later
A Mbx Biosciences director paid $1.02M out of pocket for Mbx Biosciences shares. 2 other people at Mbx Biosciences bought some too, in the same month.
ORBIMED ADVISORS LLC, Director's past purchases, 90 days after disclosure: 6 buys, median −44.0 pts vs S&P 500, beat it 2 of 6 times. Past results, not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.